AAAAAA
Results:
1-21
|
Results: 21
Authors:
GLAZER S
Citation: S. Glazer, HOLOGRAPHY Q-AND-A - AN INTERVIEW WITH GLAZER,STEWART, Cereal foods world, 43(6), 1998, pp. 422-423
Authors:
JEFFES E
MCCULLOUGH J
WEINSTEIN G
SHULL T
KAPLAN R
GLAZER S
TAYLOR R
Citation: E. Jeffes et al., PHOTODYNAMIC THERAPY OF PATIENTS HAVING MULTIPLE ACTINIC KERATOSES WITH TOPICAL 5-AMINOLEVULINIC ACID (ALA) AND NONLASER BLUE-LIGHT, Journal of investigative dermatology, 110(4), 1998, pp. 680-680
Authors:
BERNSTEIN DE
JEFFERS L
ERHARDTSEN E
REDDY KR
GLAZER S
SQUIBAN P
BECH R
HEDNER U
SCHIFF ER
Citation: De. Bernstein et al., RECOMBINANT FACTOR VIIA CORRECTS PROTHROMBIN TIME IN CIRRHOTIC-PATIENTS - A PRELIMINARY-STUDY, Gastroenterology, 113(6), 1997, pp. 1930-1937
Authors:
ISSITT C
GOMEZ R
PENG M
MACERA M
KUNDU S
HEILMANN E
GLAZER S
Citation: C. Issitt et al., CORRELATION OF PFA-100(TM) CLOSURE TIME WITH ABO BLOOD-GROUPS AND VON-WILLEBRAND-FACTOR ANTIGEN IN NORMAL SUBJECTS, Blood, 90(10), 1997, pp. 3011-3011
Authors:
NICOLAISEN EM
HANSEN LL
POULSEN F
GLAZER S
HEDNER U
Citation: Em. Nicolaisen et al., IMMUNOLOGICAL ASPECTS OF RECOMBINANT FACTOR VIIA (RFVIIA) IN CLINICALUSE, Thrombosis and haemostasis, 76(2), 1996, pp. 200-204
Authors:
KRISTENSEN J
KILLANDER A
HIPPE E
HELLEBERG C
ELLEGARD J
HOLM M
KUTTI J
MELLQVIST UH
JOHANSSON JE
GLAZER S
HEDNER U
Citation: J. Kristensen et al., CLINICAL-EXPERIENCE WITH RECOMBINANT FACTOR VIIA IN PATIENTS WITH THROMBOCYTOPENIA, Haemostasis, 26, 1996, pp. 159-164
Authors:
BERNSTEIN DE
GLAZER S
JEFFERS LJ
REDDY KR
SQUIBAN P
BECH RN
ROACH K
SEALE R
ERHARDTSEN E
SCHIFF ER
Citation: De. Bernstein et al., THE EFFECT OF RECOMBINANT FACTOR VIIA (RFVIIA) ON THE HEMATOLOGICAL PARAMETERS OF DIFFUSE INTRAVASCULAR COAGULATION (DIC) IN CIRRHOTIC-PATIENTS (PTS), Hepatology, 23(1), 1996, pp. 8-8
Authors:
GLAZER S
KRUSE B
Citation: S. Glazer et B. Kruse, INTERACTION EFFECTS OF JOB STRESS AND ORGANIZATIONAL COMMITMENT ON INTENTION TO LEAVE, International journal of psychology, 31(3-4), 1996, pp. 84160-84160
Authors:
GLAZER S
Citation: S. Glazer, 'UNTOLD TALES', The American scholar, 65(3), 1996, pp. 430-432
Authors:
ERHARDTSEN E
EZBAN M
MADSEN MT
DINESS V
GLAZER S
HEDNER U
NORDFANG O
Citation: E. Erhardtsen et al., BLOCKING OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) SHORTENS THE BLEEDING-TIME IN RABBITS WITH ANTIBODY-INDUCED HEMOPHILIA-A, Blood coagulation & fibrinolysis, 6(5), 1995, pp. 388-394
Authors:
BECH RM
NICOLAISEN EM
ANDERSEN PM
GLAZER S
HEDNER U
Citation: Rm. Bech et al., RECOMBINANT FACTOR-VIIA FOR THE TREATMENT OF CONGENITAL FACTOR-VII DEFICIENT PATIENTS, Thrombosis and haemostasis, 73(6), 1995, pp. 983-983
Authors:
FFRENCH P
NONY P
ERHARDTSEN E
DELAIR S
GIRARD P
DECHAVANNE M
BOISSEL JP
GLAZER S
Citation: P. Ffrench et al., DOSE-EFFECT RELATIONS OF RECOMBINANT FACTOR-VIIA (RFVIIA) IN HEALTHY-SUBJECTS PRETREATED WITH ACENOCOUMAROL, Thrombosis and haemostasis, 73(6), 1995, pp. 984-984
Authors:
ERHARDTSEN E
NONY P
FFRENCH P
DECHAVANNE M
BOISSEL JP
HANSEN LL
HEDNER U
GLAZER S
Citation: E. Erhardtsen et al., FURTHER SAFETY INFORMATION ON THE USE OF FACTOR-VIIA (RFVIIA) IN ACENOCOUMAROL TREATED VOLUNTEERS - A PHASE-1 STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 984-984
Authors:
BERNSTEIN DE
GLAZER S
JEFFERS LJ
SQUIBAN P
REDDY KR
ROACH K
SEALE R
ERHARDTSEN E
SCHIFF ER
Citation: De. Bernstein et al., RECOMBINANT VIIA (RFVLLA) IN THE TREATMENT OF PROLONGED PROTHROMBIN TIMES (PT) IN CIRRHOTICS, Hepatology, 22(4), 1995, pp. 730-730
Authors:
GLAZER S
Citation: S. Glazer, RECOMBINANT ACTIVATED FACTOR-VII - SAFETY AND EFFICACY, Transfusion, 34(8), 1994, pp. 728-728
Authors:
LINDLEY CM
SAWYER WT
MACIK BG
LUSHER J
HARRISON JF
BAIRDCOX K
BIRCH K
GLAZER S
ROBERTS HR
Citation: Cm. Lindley et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT FACTOR VIIA, Clinical pharmacology and therapeutics, 55(6), 1994, pp. 638-648
THE SAFETY OF RECOMBINANT FACTOR-VIIA (RFVIIA) IN ACENOCOUMAROL TREATED VOLUNTEERS - A PHASE-1 STUDY
Authors:
ERHARDTSEN E
NONY P
FFRENCH P
DECHAVANNE M
BOISSEL JP
LYNG HL
HEDNER U
GLAZER S
Citation: E. Erhardtsen et al., THE SAFETY OF RECOMBINANT FACTOR-VIIA (RFVIIA) IN ACENOCOUMAROL TREATED VOLUNTEERS - A PHASE-1 STUDY, Blood, 84(10), 1994, pp. 10000067-10000067
Authors:
BECH RBM
NIELSEN L
FALCH JF
GLAZER S
HEDNER U
Citation: Rbm. Bech et al., EVALUATION OF EFFICACY OF RECOMBINANT FACTOR-VIIA IN 149 PATIENTS TREATED FOR CRITICAL BLEEDS, Blood, 84(10), 1994, pp. 10000068-10000068
Authors:
MACIK BG
LINDLEY CM
LUSHER J
SAWYER WT
BLOOM AL
HARRISON JF
BAIRDCOX K
BIRCH K
GLAZER S
ROBERTS HR
Citation: Bg. Macik et al., SAFETY AND INITIAL CLINICAL EFFICACY OF 3 DOSE LEVELS OF RECOMBINANT ACTIVATED FACTOR-VII (RFVIIA) - RESULTS OF A PHASE-I STUDY, Blood coagulation & fibrinolysis, 4(4), 1993, pp. 521-527
Authors:
ERHARDTSEN E
MADSEN MT
EZBAN M
HEDNER U
DINESS V
GLAZER S
NORDFANG O
Citation: E. Erhardtsen et al., BLOCKING OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) SHORTENS THE BLEEDING-TIME IN RABBITS WITH ANTIBODY-INDUCED HEMOPHILIA-A, Thrombosis and haemostasis, 69(6), 1993, pp. 556-556
Authors:
THIIS JJ
RASMUSSEN S
MOERCH M
GLAZER S
MADSEN P
Citation: Jj. Thiis et al., PLASMA KINETICS OF RECOMBINANT APROTININ DOSED PER KG BODY-WEIGHT IN PATIENTS UNDERGOING CORONARY-ARTERY BYPASS GRAFT-SURGERY, Thrombosis and haemostasis, 69(6), 1993, pp. 1288-1288
Risultati:
1-21
|